AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,691,000 | +98.1% | 243,976 | -1.8% | 0.00% | +100.0% |
Q2 2022 | $1,863,000 | +238.1% | 248,399 | +310.6% | 0.00% | +100.0% |
Q1 2022 | $551,000 | +60.2% | 60,500 | +182.0% | 0.00% | – |
Q2 2021 | $344,000 | -76.8% | 21,456 | -65.0% | 0.00% | -100.0% |
Q4 2019 | $1,482,000 | -61.2% | 61,338 | -69.1% | 0.00% | -75.0% |
Q3 2019 | $3,819,000 | +1427.6% | 198,669 | +3506.9% | 0.00% | – |
Q1 2017 | $250,000 | -94.6% | 5,508 | -95.5% | 0.00% | -100.0% |
Q3 2016 | $4,600,000 | +162.9% | 121,896 | +22.6% | 0.01% | +166.7% |
Q2 2016 | $1,750,000 | +168.0% | 99,451 | +270.6% | 0.00% | +200.0% |
Q4 2015 | $653,000 | -20.3% | 26,833 | -41.9% | 0.00% | 0.0% |
Q3 2015 | $819,000 | +103.7% | 46,189 | +102.6% | 0.00% | 0.0% |
Q2 2015 | $402,000 | – | 22,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |